Profiel
Stephen T.
Isaacs is the founder of Cerus Corp.
which was founded in 1991.
He was the President & Chief Executive Officer of Cerus Corp.
from 1991 to 2004.
Currently, he is the Chairman of X-Biotix Therapeutics, Inc. since 2018 and also the Director of the Center for Global Development.
He was also a Principal at the University of California, Berkeley from 1986 to 1986.
Mr. Isaacs received his undergraduate degree from the University of California, Berkeley in 1973.
Actieve functies van Stephen T. Isaacs
| Bedrijven | Functie | Begin |
|---|---|---|
X-Biotix Therapeutics, Inc.
X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Voorzitter | 01-04-2018 |
Center for Global Development
Center for Global Development Miscellaneous Commercial ServicesCommercial Services Works to reduce global poverty and inequality through research | Directeur/Bestuurslid | - |
Eerdere bekende functies van Stephen T. Isaacs
| Bedrijven | Functie | Einde |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Algemeen Directeur | 05-10-2020 |
Oncologic, Inc.
Oncologic, Inc. BiotechnologyHealth Technology Develops patented technology for cancer treatment | President | 02-06-2008 |
| CERUS CORPORATION | Algemeen Directeur | 01-01-2004 |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-1986 |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Algemeen Directeur | - |
Opleiding van Stephen T. Isaacs
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Cerus Corp.
Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
Oncologic, Inc.
Oncologic, Inc. BiotechnologyHealth Technology Develops patented technology for cancer treatment | Health Technology |
Aduro BioTech, Inc.
Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company, which focuses on the development of technology platforms for cancer | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Center for Global Development
Center for Global Development Miscellaneous Commercial ServicesCommercial Services Works to reduce global poverty and inequality through research | Commercial Services |
X-Biotix Therapeutics, Inc.
X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
















